Medicinal Cannabis is cannabis that is grown and sold pursuant to the Medicinal Cannabis Industry Act, 2019 that includes the seeds, immature plants as well as all parts of the plant, along with resin extracted from any part of the plant, every compound, manufacture, salt, derivative, mixture or preparation from cannabis; or cannabis concentrate; that is cultivated, processed, manufactured, distributed or sold under a licence from the BMCLA. As a medicine, it is prescribed and recommended by physicians to provide a therapeutic effect.

Cannabidiol (CBD) is one of the bioactive compounds and naturally occurring cannabinoids in the cannabis plant. It is one of the most medically relevant chemical compounds found in the cannabis plant, but it’s different from THC because of its opposing antagonistic effect compared to THC. It is also not as psychoactive as THC and is noted more for its medicinal effects.

• develops policies, procedures and guidelines to establish the medicinal cannabis industry and to ensure that medicinal cannabis is available to patients in a safe and efficient manner;

• regulates the handling of medicinal cannabis;

• issues licences in relation to the handling of medicinal cannabis in accordance with the provisions of the Barbados Medicinal Industry Act;

• develops enforcement procedures in relation to the inspection of premises that are operated by a person in order to ensure compliance with the provisions of the Barbados Medicinal Industry Act or any regulations made pursuant to this Act;

• where required, assists with the provision of analytical services;

• with the approval of the Barbados Medicinal Cannabis Licensing Board, establishes and maintains an electronic database to:

  • Collect, collate and include information relating to persons who handle medicinal cannabis or cannabis in accordance with this Act; and

  • Provide for the electronic tracking of the handling of medicinal cannabis or cannabis in accordance with the Barbados Medicinal Industry Act;

• with the approval of the Barbados Medicinal Cannabis Licensing Board, requests from the Minister of Health such information as may assist the BMCLA with its functions;

• provides for the distribution of educational materials and the conduct of training programmes in relation to the development and use of medicinal cannabis and the medicinal cannabis industry;

• ensures that proper disposal requirements are prescribed for the safe disposal of cannabis which is handled under the Barbados Medicinal Industry Act;

• performs such other functions assigned to it under the Barbados Medicinal Industry Act or any other enactment; and

• enters into any arrangement, which, in the opinion of the BMCLA, is necessary to ensure the proper performance of its functions.

There are two major concerns regarding smoking medicinal cannabis.

Firstly, smoking is a particularly harmful way of taking medicinal cannabis, mainly because it poses comparable risks for bronchitis and lung cancer, as is the smoking of cigarettes. Smoking medicinal cannabis is not permitted by local or international Health authorities.

Secondly, approved medicines used in Barbados are produced under strict conditions to ensure efficacy and safety. It is important that medical doctors know that medicines have been tested and are standardized by dose and therapeutic response. This means doctors can monitor the effects of the drug and doses can be adjusted according to a patient’s needs.

It is understood that smoked cannabis will not be prescribed in Barbados because smoked plant products will not satisfy governmental requirements.